tiprankstipranks
Trending News
More News >
ADM Tronics Unlimited Inc (ADMT)
OTHER OTC:ADMT
US Market
Advertisement

ADM Tronics Un (ADMT) AI Stock Analysis

Compare
17 Followers

Top Page

ADMT

ADM Tronics Un

(OTC:ADMT)

Rating:50Neutral
Price Target:
ADM Tronics Unlimited's score is primarily impacted by its challenging financial performance, marked by persistent losses and negative cash flow. The technical analysis suggests a lack of strong momentum in either direction, while the valuation reflects the company's unprofitable status, resulting in a lower overall score.

ADM Tronics Un (ADMT) vs. SPDR S&P 500 ETF (SPY)

ADM Tronics Un Business Overview & Revenue Model

Company DescriptionADM Tronics Unlimited (ADMT) is a diversified technology company engaged in the development, manufacturing, and marketing of innovative technologies across multiple sectors. The company primarily focuses on electronics for non-invasive medical devices, therapeutic medical technology, and environmentally friendly chemical products. ADMT leverages its expertise in electronics and materials science to provide solutions that meet the needs of healthcare and industrial applications.
How the Company Makes MoneyADM Tronics Unlimited generates revenue through the sale of its proprietary electronic medical devices and specialized chemical products. Its key revenue streams include the manufacturing and distribution of non-invasive medical devices used in therapeutic and diagnostic applications, as well as environmentally safe chemical solutions for industrial use. The company also engages in contract manufacturing and research and development services for third parties, which provides an additional income source. Strategic partnerships with medical device companies and industrial firms further contribute to its earnings by expanding product reach and enhancing technological capabilities.

ADM Tronics Un Financial Statement Overview

Summary
ADM Tronics Unlimited faces significant financial hurdles, with consistent losses impacting profitability and cash flow. While there are some signs of revenue stabilization, the company's financial position is strained. The balance sheet shows a reasonable debt level, but ongoing net losses and negative cash flow underline the need for strategic adjustments to improve financial health.
Income Statement
45
Neutral
The income statement shows a challenging financial performance with negative net income and declining EBIT and EBITDA margins. Although there is a slight improvement in revenue for the TTM period, the company has been struggling with profitability, as evidenced by consistently negative net income and EBIT over the years.
Balance Sheet
50
Neutral
The balance sheet reflects moderate financial stability with a manageable debt-to-equity ratio. However, the equity ratio has been decreasing, indicating increasing leverage over time. The return on equity remains negative due to persistent net losses, which is a concern for long-term investor returns.
Cash Flow
40
Negative
The cash flow statement highlights a negative free cash flow position, exacerbated by negative operating cash flow. The operating cash flow to net income ratio and free cash flow to net income ratio indicate cash flow challenges, with limited improvements in cash generation relative to income losses.
BreakdownDec 2023Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue2.85M3.68M3.21M3.09M3.49M
Gross Profit1.09M1.66M1.25M1.16M1.57M
EBITDA-514.02K80.35K-1.02M-506.36K21.75K
Net Income-716.85K-96.32K-1.38M-598.28K-95.76K
Balance Sheet
Total Assets2.14M3.09M3.25M5.21M5.05M
Cash, Cash Equivalents and Short-Term Investments537.04K1.00M1.04M1.55M1.44M
Total Debt799.66K752.69K918.31K1.58M757.76K
Total Liabilities1.45M1.52M1.88M2.46M1.71M
Stockholders Equity692.39K1.57M1.37M2.76M3.34M
Cash Flow
Free Cash Flow-599.65K125.02K-574.95K-769.64K55.10K
Operating Cash Flow-585.13K125.02K-574.95K-769.64K69.96K
Investing Cash Flow-14.52K0.000.000.00-14.86K
Financing Cash Flow165.18K-258.56K66.50K877.87K-172.07K

ADM Tronics Un Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.05
Price Trends
50DMA
0.05
Positive
100DMA
0.06
Positive
200DMA
0.07
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
55.92
Neutral
STOCH
58.48
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADMT, the sentiment is Positive. The current price of 0.05 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 55.92 is Neutral, neither overbought nor oversold. The STOCH value of 58.48 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ADMT.

ADM Tronics Un Risk Analysis

ADM Tronics Un disclosed 17 risk factors in its most recent earnings report. ADM Tronics Un reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ADM Tronics Un Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$165.12M24.0116.56%14.85%64.96%
58
Neutral
$2.35B-376.89%26.27%15.58%
52
Neutral
$122.96M-13.49%3.21%-6985.88%
51
Neutral
$7.76B-0.12-40.59%2.21%22.68%-1.42%
50
Neutral
$3.71M-6.71%8.25%85.71%
48
Neutral
$19.88M-105.72%0.09%51.09%
32
Underperform
$4.10K89.50%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADMT
ADM Tronics Un
0.06
0.00
0.00%
ATEC
Alphatec Holdings
15.89
10.21
179.75%
ELMD
Electromed
19.61
4.75
31.97%
IRIX
Iridex
1.28
-0.71
-35.68%
KNDI
Kandi Technologies
1.65
-0.08
-4.62%
PBIO
Pressure Biosciences
0.02
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 01, 2025